X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (788) 788
Publication (83) 83
Book Review (40) 40
Book Chapter (12) 12
Book / eBook (11) 11
Conference Proceeding (2) 2
Data Set (2) 2
Newsletter (2) 2
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (533) 533
multiple sclerosis (514) 514
humans (470) 470
animals (401) 401
female (298) 298
neurosciences (283) 283
neurology (276) 276
immunology (247) 247
mice (238) 238
demyelination (233) 233
multiple-sclerosis (231) 231
experimental autoimmune encephalomyelitis (219) 219
central-nervous-system (218) 218
male (217) 217
central nervous system (202) 202
medicine (201) 201
research article (198) 198
autoimmune diseases (189) 189
inflammation (186) 186
clinical neurology (183) 183
multidisciplinary sciences (181) 181
demyelinating disorders (178) 178
science (175) 175
demyelinating diseases (172) 172
research (169) 169
nervous system (156) 156
disease models, animal (149) 149
experimental allergic encephalomyelitis (148) 148
clinical immunology (146) 146
adult (144) 144
multiple sclerosis - drug therapy (133) 133
mice, inbred c57bl (132) 132
disease (118) 118
multiple sclerosis - pathology (115) 115
demyelinating diseases - pathology (113) 113
middle aged (112) 112
rodents (107) 107
encephalomyelitis (106) 106
analysis (105) 105
care and treatment (104) 104
demyelinating diseases - drug therapy (104) 104
patients (104) 104
biology (99) 99
magnetic resonance imaging (98) 98
cytokines (97) 97
lymphocytes (96) 96
neurodegenerative diseases (96) 96
biology and life sciences (95) 95
brain (95) 95
health aspects (94) 94
proteins (93) 93
medicine and health sciences (92) 92
multiple sclerosis - immunology (91) 91
myelin (91) 91
encephalomyelitis, autoimmune, experimental - drug therapy (90) 90
animal models (88) 88
cell biology (88) 88
lymphocytes t (88) 88
encephalomyelitis, autoimmune, experimental - pathology (83) 83
t cells (82) 82
encephalomyelitis, autoimmune, experimental - immunology (81) 81
clinical medicine (80) 80
neuroscience (80) 80
rats (76) 76
immune system (75) 75
pathology (75) 75
autoimmunity (73) 73
demyelinating disease (73) 73
remyelination (73) 73
development and progression (70) 70
pharmacology & pharmacy (69) 69
physiological aspects (69) 69
gene expression (67) 67
immune cells (66) 66
spinal cord (66) 66
expression (65) 65
article (63) 63
spinal cord - pathology (63) 63
studies (63) 63
immunomodulation (62) 62
pathogenesis (62) 62
lesions (61) 61
multiple sclerosis - metabolism (61) 61
oligodendrocytes (61) 61
risk factors (61) 61
cells, cultured (59) 59
differentiation (59) 59
therapy (59) 59
diagnosis (58) 58
myelination (58) 58
biochemistry (57) 57
drug therapy (57) 57
medical research (57) 57
interferon (56) 56
treatment outcome (55) 55
antigens (54) 54
brain - pathology (54) 54
research and analysis methods (54) 54
brain research (53) 53
microglia (51) 51
more...
Library Location Library Location
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Annals of Neurology, ISSN 0364-5134, 03/2009, Volume 65, Issue 3, pp. 304 - 315
Journal Article
Journal of Neuroimmunology, ISSN 0165-5728, 2016, Volume 298, pp. 9 - 15
Journal Article
Journal Article
Clinical Neurophysiology, ISSN 1388-2457, 10/2018, Volume 129, Issue 10, pp. 2162 - 2169
Journal Article
Journal Article
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2004, Volume 101, Issue 46, pp. 16363 - 16368
Chronic disabilities in multiple sclerosis are believed to be due to neuron damage and degeneration, which follow remyelination failure. Due to the presence of... 
Biological Sciences | Spinal cord | Relapse | Nervous system diseases | Messenger RNA | Demyelinating diseases | Myelin | Central nervous system | Oligodendroglia | Myelin sheath | Spinal cord diseases | Neuroprotection | Multiple sclerosis | Rat | Oligodendrocyte precursor cells | Axonal pathology | EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS | MULTIPLE-SCLEROSIS LESIONS | rat | multiple sclerosis | MULTIDISCIPLINARY SCIENCES | EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS | SPINAL-CORD | axonal pathology | SUBVENTRICULAR ZONE | oligodendrocyte precursor cells | NEURAL STEM-CELLS | MAGNETIC-RESONANCE-SPECTROSCOPY | neuroprotection | CENTRAL-NERVOUS-SYSTEM | GROWTH-FACTOR | Demyelinating Autoimmune Diseases, CNS - metabolism | Thyroxine - administration & dosage | Rats, Inbred Lew | Myelin Sheath - drug effects | Demyelinating Autoimmune Diseases, CNS - drug therapy | RNA, Messenger - metabolism | Myelin Sheath - metabolism | Myelin Basic Protein - genetics | Demyelinating Autoimmune Diseases, CNS - genetics | Female | Disease Models, Animal | Immunization | Encephalomyelitis, Autoimmune, Experimental - pathology | Guinea Pigs | Myelin Basic Protein - metabolism | Myelin Sheath - pathology | Demyelinating Autoimmune Diseases, CNS - pathology | Encephalomyelitis, Autoimmune, Experimental - drug therapy | RNA, Messenger - genetics | Rats | Spinal Cord - immunology | Animals | Myelin Sheath - genetics | Multiple Sclerosis - pathology | Multiple Sclerosis - drug therapy | Research | Thyroid hormones | Proteins | Neurology | Thyroid gland | Hormones | Neurons | Rodents
Journal Article
Journal Article
Journal of Neurotrauma, ISSN 0897-7151, 12/2009, Volume 26, Issue 12, pp. 2335 - 2344
A robust and complex inflammatory cascade is known to be a prominent component of secondary injury following spinal cord injury (SCI). Specifically, the... 
Locomotor function | Behavioral assessment | Inflammation | Spinal cord injury | FTY720 | spinal cord injury | CELLS | locomotor function | MACROPHAGES | behavioral assessment | MOTOR FUNCTION | RATS | CNS | ACTIVE IMMUNIZATION | LYMPHOCYTE EGRESS | NEUROSCIENCES | CLINICAL NEUROLOGY | PROTECTIVE AUTOIMMUNITY | inflammation | MICROGLIA | SPHINGOSINE-1-PHOSPHATE | CRITICAL CARE MEDICINE | Spinal Cord Injuries - drug therapy | Paralysis - drug therapy | Recovery of Function - drug effects | Immunosuppressive Agents - therapeutic use | Rats, Long-Evans | Nerve Regeneration - immunology | Demyelinating Autoimmune Diseases, CNS - drug therapy | Demyelinating Autoimmune Diseases, CNS - immunology | Demyelinating Autoimmune Diseases, CNS - physiopathology | Myelitis - drug therapy | Urinary Bladder, Neurogenic - physiopathology | Wallerian Degeneration - drug therapy | Lymphocyte Activation - immunology | Flow Cytometry | Chemotaxis, Leukocyte - drug effects | Myelitis - immunology | Autoimmunity - immunology | Nerve Fibers, Myelinated - pathology | T-Lymphocytes - drug effects | Propylene Glycols - therapeutic use | Immunosuppressive Agents - pharmacology | Paralysis - etiology | Disease Models, Animal | Propylene Glycols - pharmacology | Myelitis - physiopathology | Nerve Fibers, Myelinated - drug effects | Wallerian Degeneration - physiopathology | Fingolimod Hydrochloride | Rats | Treatment Outcome | Urinary Bladder, Neurogenic - drug therapy | Wallerian Degeneration - immunology | Sphingosine - pharmacology | Recovery of Function - immunology | Sphingosine - analogs & derivatives | Animals | Lymphocyte Activation - drug effects | Nerve Fibers, Myelinated - immunology | Nerve Regeneration - drug effects | Paralysis - physiopathology | Sphingosine - therapeutic use | Spinal Cord Injuries - immunology | T-Lymphocytes - immunology | Spinal Cord Injuries - physiopathology | Chemotaxis, Leukocyte - immunology | Urinary Bladder, Neurogenic - immunology | Autoimmunity - drug effects | Prevention | Physiological aspects | Spinal cord injuries | Research | Biological response modifiers | Inflammatory diseases | Behavior | Original
Journal Article